Sector
PharmaceuticalsOpen
₹58Prev. Close
₹58Turnover(Lac.)
₹1.15Day's High
₹58Day's Low
₹57.9552 Week's High
₹85.552 Week's Low
₹46.15Book Value
₹39.71Face Value
₹10Mkt Cap (₹ Cr.)
43.72P/E
50.83EPS
1.14Divi. Yield
010 Sep 2024
12:00 AM
AGM
Announcement Date: 10 Sep, 2024
24 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 7.55 | 7.55 | 7.55 | 7.55 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 21.46 | 19.93 | 19.13 | 18.33 |
Net Worth | 29.01 | 27.48 | 26.68 | 25.88 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 |
|---|---|---|
Revenue | 93.98 | 106.27 |
yoy growth (%) | -11.57 | |
Raw materials | -85.79 | -92.36 |
As % of sales | 91.29 | 86.91 |
Employee costs | -2.44 | -4.71 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 |
|---|---|---|
Profit before tax | 0.42 | 0.88 |
Depreciation | -0.03 | -0.05 |
Tax paid | -0.1 | -0.19 |
Working capital | 12.58 | |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2019 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | -11.57 | |
Op profit growth | -27.47 | |
EBIT growth | -24.64 | |
Net profit growth | -54.28 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,682.05 | 94.39 | 4,03,580.14 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,783.05 | 81.52 | 1,80,068.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484.6 | 24.91 | 1,19,918.75 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,407.05 | 60.94 | 1,15,304.87 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,699.8 | 59.14 | 1,11,428.51 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Hemant C Bhagat
Whole-time Director
Pranav H Bhagat
Director & CFO
Prachi Pranav Bhagat
Independent Director
Ravindra Gajanan Awati
Independent Director
Abha Praveen Doshi
Company Sec. & Compli. Officer
Rajni Dawani
323-F Bhagat Bhuvan,
Dr Ambedkar Road Matunga (E),
Maharashtra - 400019
Tel: 91-22-24146154
Website: http://www.cbcpharma.com
Email: compliance@cbcpharma.net
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name Chandra Bhagat Pharma Private Limited at Mumbai on March 10, 2003. Consequent upon the conversion of the Compa...
Read More
Reports by Chandra Bhagat Pharma Ltd
What is the Chandra Bhagat Pharma Ltd share price today?
What is the Market Cap of Chandra Bhagat Pharma Ltd?
What is the PE and PB ratio of Chandra Bhagat Pharma Ltd?
What is the 52 Week High and Low of Chandra Bhagat Pharma Ltd?
What is the CAGR of Chandra Bhagat Pharma Ltd?
What is the shareholding pattern of Chandra Bhagat Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.